UK markets closed

Vistin Pharma ASA (VISTN.OL)

Oslo - Oslo Delayed price. Currency in NOK
Add to watchlist
23.30-0.10 (-0.43%)
At close: 04:25PM CEST
Currency in NOK

Valuation measures4

Market cap (intra-day) 1.04B
Enterprise value 1.01B
Trailing P/E 18.43
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.37
Price/book (mrq)3.49
Enterprise value/revenue 2.31
Enterprise value/EBITDA 12.71

Trading information

Stock price history

Beta (5Y monthly) 0.90
52-week change 34.93%
S&P500 52-week change 322.43%
52-week high 325.10
52-week low 320.60
50-day moving average 323.00
200-day moving average 323.05

Share statistics

Avg vol (3-month) 329.67k
Avg vol (10-day) 321.67k
Shares outstanding 544.34M
Implied shares outstanding 644.34M
Float 818.91M
% held by insiders 154.76%
% held by institutions 112.77%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.25
Forward annual dividend yield 45.34%
Trailing annual dividend rate 31.00
Trailing annual dividend yield 34.27%
5-year average dividend yield 4N/A
Payout ratio 459.06%
Dividend date 3N/A
Ex-dividend date 405 Jun 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 12.75%
Operating margin (ttm)15.17%

Management effectiveness

Return on assets (ttm)11.82%
Return on equity (ttm)19.84%

Income statement

Revenue (ttm)441.27M
Revenue per share (ttm)9.95
Quarterly revenue growth (yoy)2.90%
Gross profit (ttm)N/A
EBITDA 92.25M
Net income avi to common (ttm)56.28M
Diluted EPS (ttm)1.27
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)11.4M
Total cash per share (mrq)0.26
Total debt (mrq)30.61M
Total debt/equity (mrq)10.30%
Current ratio (mrq)1.62
Book value per share (mrq)6.70

Cash flow statement

Operating cash flow (ttm)73.95M
Levered free cash flow (ttm)48.25k